By Khushi Malhotra and Dharamraj Dhutia MUMBAI, Sept 29 (Reuters) – India's Sun Pharmaceutical Industries is planning to raise around 100 billion rupees ($1.04 billion) via a rupee-denominated debt
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Meta expands Muse AI agent for small businesses
Sept 29 (Reuters) - Meta Platforms is expanding its AI agent Muse to small businesses,…
Meta expands Muse AI agent for small businesses
Sept 29 (Reuters) - Meta Platforms is expanding its AI agent Muse to small businesses,…
Why ‘Largest’ Isn’t the Same as ‘Trusted’: How COWBERRY Is Testing Its Way to Both
Every one of COWBERRY’s 150+ SKUs is screened for 252+ banned chemical residues before listing.New…
